Asia-Pacific Americas Africa Europe Middle East

SRI KRISHNA PHARMACEUTICALS LTD

Company Profile:

Company Type: Manufacturer (Factory)

Company Introduction:

SRI KRISHNA PHARMACEUTICALS LTD (SKPL) is a leading Indian pharmaceutical company established on March 7, 1990. It operates as a vertically integrated bulk drug and formulations manufacturer, classifying it as a factory rather than solely a trading entity.

SKPL is renowned globally as one of the largest manufacturers of Paracetamol. The company specializes in the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and finished dosage forms. With a strong emphasis on research and development, quality assurance, and robust manufacturing capabilities, SKPL serves both domestic and international markets. Their operations cover the entire spectrum from raw material sourcing to the development and production of a wide range of pharmaceutical products.

Enterprise Products



Product Categories:

Active Pharmaceutical Ingredients (APIs)

Pharmaceutical Intermediates

Finished Dosage Forms (Tablets, Capsules, Oral Solutions)

Key Products (Examples of APIs):

Paracetamol (Acetaminophen)

Ibuprofen

Metformin Hydrochloride

Gabapentin

Ranitidine Hydrochloride

Ondansetron Hydrochloride

Levetiracetam

Fexofenadine Hydrochloride

Cetirizine Hydrochloride

Montelukast Sodium

Sildenafil Citrate

Tadalafil

Pantoprazole Sodium

Esomeprazole Magnesium

Pregabalin

Domperidone

Rabeprazole Sodium

And various other APIs and their corresponding intermediates for therapeutic areas including analgesics, anti-diabetics, anti-epileptics, anti-allergics, gastrointestinal drugs, and cardiovascular drugs.

Business Registration Information:

Manager:

Mr. V.V. Krishna Reddy (Chairman and Managing Director)

Phone:

+91 40 2720 0000

E-mail:

info@srikrishnapharma.com

Official Website:
Address:

C-4, Industrial Area, Uppal, Hyderabad - 500 039, Telangana, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.